Horizon Europe Article 19 (Ethics)

What Article 19 of Regulation (EU) 2021/695 is

Article 19, titled "Ethics," is the general ethics clause of the Horizon Europe framework Regulation — Regulation (EU) 2021/695 of the European Parliament and of the Council, which establishes Horizon Europe (2021–2027) and lays down its rules for participation and dissemination. It requires that all actions carried out under the programme comply with ethical principles and with relevant Union, national, and international law, including the Charter of Fundamental Rights of the European Union and the European Convention for the Protection of Human Rights and Fundamental Freedoms and its supplementary protocols. The article singles out particular attention to the principle of proportionality, the right to privacy, the right to protection of personal data, the right to the physical and mental integrity of a person, the right to non-discrimination, and the need to ensure protection of the environment and high levels of human health protection. Article 19 sits alongside the Horizon Europe rules on funding eligibility and works together with the programme’s ethics appraisal procedure, which is operationalised through the proposal template, the Grant Agreement, and Commission (or funding-body) ethics review rather than through Article 19’s text alone.

Ethics self-assessment at proposal stage

In practice, Article 19 is first encountered by applicants through the mandatory ethics self-assessment section of the Horizon Europe proposal application form. Applicants must answer a structured set of trigger questions covering areas such as human participants, human cells or tissues, personal data, animals, non-EU/non-associated-country activity, environment/health/safety, and dual-use or misuse potential. A "yes" answer to any trigger question requires the applicant to describe, in an ethics self-assessment narrative, how the relevant ethical and legal requirements will be met (e.g., informed consent procedures, data protection safeguards, or the ethics/regulatory approvals that will be sought). This self-assessment becomes part of the proposal that is evaluated and, if the project is funded, of the record the Commission or funding body can revisit throughout the grant.

Screening and ethics assessment procedure

Proposals are systematically screened by the Commission (or the relevant funding body, such as an executive agency) to identify those that raise complex or serious ethics issues. Proposals identified at screening are submitted to a formal ethics assessment, carried out with the support of independent ethics experts. Article 19 specifies that all actions involving the use of human embryonic stem cells or human embryos are subject to ethics assessment as a matter of course, regardless of what the self-assessment screening would otherwise indicate. Where a project is funded, Article 19 also allows for ethics checks during implementation and, in specific cases, ethics audits — the obligation to comply is continuous across the life of the grant, not a gate that is passed once at proposal stage and then closed.

Approvals participating entities must hold

Beyond the Commission-level screening/assessment procedure, Article 19 requires that legal entities participating in a funded action obtain all approvals or other mandatory documents required by relevant national or local ethics committees, or by other competent bodies such as national data protection authorities, before the start of the relevant activities. Those approvals and documents must be kept on file by the beneficiary and made available to the Commission or funding body on request. This means a Horizon Europe ethics assessment at Commission level does not substitute for, and cannot pre-empt, the ordinary national or institutional ethics/regulatory approvals (e.g., an institutional research ethics committee or REC opinion, or a national data protection authority authorisation) that the underlying research activity would otherwise require.

Research fields excluded from funding

The Horizon Europe Regulation also excludes certain fields of research from funding under the programme outright, continuing a prohibition that has applied, in substantially the same form, under successive EU Framework Programmes (including Horizon 2020’s equivalent ethics article). The excluded fields are generally described as: research aiming at human cloning for reproductive purposes; research intended to modify the genetic heritage of human beings in a way that could make such changes heritable (germline genetic modification); and research intended to create human embryos solely for the purpose of research or for the purpose of stem cell procurement, including by means of somatic cell nuclear transfer. REPORTED — this description reflects the substance of the exclusion as carried forward from prior Framework Programmes and secondary EU research-ethics guidance; readers relying on the exact sub-paragraph citation or current wording for a compliance decision should confirm it against the consolidated text of Regulation (EU) 2021/695 on EUR-Lex.

Worked example

A consortium proposing a Horizon Europe Research and Innovation Action that will collect health-related survey data and biometric samples from human participants across three member states must complete the ethics self-assessment, answering "yes" to the human-participants and personal-data trigger questions and describing planned informed-consent procedures and data-protection safeguards. Because the proposal raises non-trivial human-subjects and data-protection issues, it is flagged at screening and routed to a full ethics assessment before signature of the Grant Agreement; each participating university or hospital must also separately obtain its own institutional research ethics committee approval and keep it on file, since Commission-level ethics assessment does not replace that national/institutional step.

By contrast, a proposal studying soil-sensor network performance with no human participants, no personal data, no animal use, and no dual-use concern would answer "no" to every self-assessment trigger question. It still must comply with Article 19’s general ethics-compliance obligation, but it would not, on that basis alone, be routed to a dedicated ethics assessment.

What does not satisfy Article 19

A beneficiary that obtains a single ethics-committee approval at the very start of a multi-year project and then never revisits ethics compliance after a protocol or methodology change (for example, extending data collection to a new participant population, or changing what personal data is collected) has not satisfied Article 19 on an ongoing basis. The approvals requirement applies to activities as they begin, and the Commission or funding body retains the ability to carry out ethics checks during implementation — ethics compliance under Horizon Europe is a standing obligation across the grant’s lifecycle, not a one-time proposal-stage formality.

Related terms

See also Grant Agreement (Horizon Europe), Beneficiary (Horizon Europe), REC (Research Ethics Committee), and Ethics approval statement. For the underlying substantive debates around embryo and stem cell research ethics referenced above, see CASRAI’s guide on the Ethics of Embryonic Stem Cell Research, and for the broader principles underpinning research ethics review generally, see Principles of Research Ethics.